California Public Employees Retirement System Glycomimetics Inc Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$2.16 - $3.18 $116,856 - $172,038
-54,100 Closed
0 $0
Q2 2020

Aug 12, 2020
SELL
$2.06 - $3.76 $12,786 - $23,338
-6,207 Reduced 10.29%
54,100 $203,000
Q4 2019

Jan 27, 2020
BUY
$4.03 - $6.5 $200,694 - $323,700
49,800 Added 473.97%
60,307 $319,000
Q3 2019

Oct 31, 2019
BUY
$2.8 - $12.85 $29,419 - $135,014
10,507 New
10,507 $45,000
Q2 2018

Aug 15, 2018
SELL
$14.63 - $19.19 $149,621 - $196,256
-10,227 Closed
0 $0
Q1 2018

May 11, 2018
BUY
$16.06 - $25.35 $164,245 - $259,254
10,227 New
10,227 $166,000

Others Institutions Holding GLYC

# of Institutions
36
Shares Held
17.8M
Call Options Held
0
Put Options Held
0
View Full List

About GLYCOMIMETICS INC

GLYC Quotes by TradingView
  • Ticker GLYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,423,900
  • Market Cap $16.3M
  • Description
  • GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...
More about GLYC
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email